NTRA Q2 2021 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q2 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$142M+64.2% YoY

Gross Profit

$66M46.4% margin

Operating Income

-$115M-81.2% margin

Net Income

-$116M-81.7% margin

EPS (Diluted)

$-1.32

QoQ Revenue Growth

-6.8%

Cash Flow

Operating Cash Flow

-$71M

Free Cash Flow

-$79M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$850M

Total Liabilities

$551M

Stockholders' Equity

$299M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$142M	$86M	+64.2%
Gross Profit	$66M	$40M	+66.7%
Operating Income	-$115M	-$52M	-123.2%
Net Income	-$116M	-$60M	-94.6%

Revenue Segments

Product

$137M97%

Licensing And Other

$5M3%

Geographic Segments

U

$135M95%

E M E A

$4M3%

Other Geographic Areas

$2M1%

Americas Excluding Us

$992,0001%